1. Home
  2. REPL vs VLRS Comparison

REPL vs VLRS Comparison

Compare REPL & VLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$7.52

Market Cap

692.8M

Sector

Health Care

ML Signal

HOLD

Logo Controladora Vuela Compania de Aviacion S.A.B. de C.V.

VLRS

Controladora Vuela Compania de Aviacion S.A.B. de C.V.

HOLD

Current Price

$7.46

Market Cap

823.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
REPL
VLRS
Founded
2015
2005
Country
United States
Mexico
Employees
N/A
6901
Industry
Biotechnology: Pharmaceutical Preparations
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
692.8M
823.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
REPL
VLRS
Price
$7.52
$7.46
Analyst Decision
Buy
Buy
Analyst Count
9
8
Target Price
$11.13
$9.41
AVG Volume (30 Days)
1.3M
929.1K
Earning Date
02-03-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
5.25
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$13.69
Revenue Next Year
N/A
$12.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.68
$3.49
52 Week High
$13.24
$10.80

Technical Indicators

Market Signals
Indicator
REPL
VLRS
Relative Strength Index (RSI) 51.39 43.76
Support Level $6.81 $7.32
Resistance Level $8.07 $8.00
Average True Range (ATR) 0.50 0.35
MACD 0.02 0.10
Stochastic Oscillator 46.12 80.25

Price Performance

Historical Comparison
REPL
VLRS

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

Share on Social Networks: